Dr. Kim’s principal clinical interests include gastrointestinal cancer, breast cancer and hepatocellular carcinoma. His research interests cover both cancer genetics and epigenetics, which are key two major driver of carcinogenesis. He has broad experiences on cancer genome analysis and treatment strategies based upon it. He has also performed various studies on cancer epigenetics. He is a member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR), as well as a number of Korean medical, cancer and molecular biology societies.